In accordance with Council Decision 2013/263/EU(1), the Agreement between the European Union and the Russian Federation on drug precursors (‘the Agreement’) was signed on 4 June 2013, subject to its conclusion at a later date.

The Council approves the EU-Russia drug precursors agreement, and the Council President must give the notification required by Article 11 of the Agreement.

AI-assisted research synopsis — verify against the official legal text below.

Jurisdiction: European Union
Instrument: Decision
Citation: 32014D0318
Status: In force
Version: Undated source snapshot
Language: en
Official source: View official record ↗

agreement approval international cooperation personal data transfer

Publicly available, excluded from search-engine indexing

This page remains available for direct access and API use, but this release emits noindex,follow for the following reason:

The record does not meet this release's canonical indexing criteria. (market-indexing-disabled)

Statute overview

About this statute

This page preserves the statute’s identified version, provision structure, official source link, and stored legal text for reading and research.

Read the provisions Ask with citations

Search within this statute

Search all stored provisions in this version.

Legal text

Provisions of In accordance with Council Decision 2013/263/EU(1), the Agreement between the European Union and the Russian Federation on drug precursors (‘the Agreement’) was signed on 4 June 2013, subject to its conclusion at a later date.

Showing 1 of 1

§
In accordance with Council Decision 2013/263/EU(1), the Agreement between the European Union and the Russian Federation on drug precursors (‘the Agreement’) was signed on 4 June 2013, subject to its conclusion at a later date.
Verify source ↗

AI-assisted research summary: The Council approves the EU-Russia drug precursors agreement, and the Council President must give the notification required by Article 11 of the Agreement.

4.6.2014 | EN | Official Journal of the European Union | L 165/6 ---|---|---|--- * * * COUNCIL DECISION of 17 February 2014 on the conclusion, on behalf of the European Union, of the Agreement between the European Union and the Russian Federation on drug precursors (2014/318/EU) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty on the Functioning of the European Union, and in particular the first subparagraph of Article 207(4), in conjunction with Article 218(6)(a) thereof, Having regard to the proposal from the European Commission, Having regard to the consent of the European Parliament, Whereas: (1) | The European Union and the Russian Federation should strengthen their cooperation to prevent diversion of drug precursors from the legal trade, in order to counter the illicit manufacture of narcotic drugs and psychotropic substances. ---|--- (2) | In accordance with Council Decision 2013/263/EU (1), the Agreement between the European Union and the Russian Federation on drug precursors (‘the Agreement’) was signed on 4 June 2013, subject to its conclusion at a later date. ---|--- (3) | The Agreement should ensure full respect of fundamental rights, in particular a high level of protection for the processing and transfer of personal data between the Parties to the Agreement. ---|--- (4) | The Agreement should be approved on behalf of the European Union, ---|--- HAS ADOPTED THIS DECISION: Article 1 The Agreement between the European Union and the Russian Federation on drug precursors is hereby approved on behalf of the Union. The text of the Agreement is attached to this Decision. Article 2 The President of the Council shall, on behalf of the European Union, give the notification provided for in Article 11 of the Agreement (2). Article 3 This Decision shall enter into force on the day of its adoption. Done at Brussels, 17 February 2014. For the Council The President A. TSAFTARIS * * * (1) Council Decision 2013/263/EU of 13 May 2013 on the signing, on behalf of the European Union, of the Agreement between the European Union and the Russian Federation on drug precursors (OJ L 154, 6.6.2013, p. 5). (2) The date of entry into force of the Agreement will be published in the Official Journal of the European Union by the General Secretariat of the Council. * * *

Provision text is displayed from LexChat’s stored statute record. Use the official source links to verify amendments, commencement, and current legal force.

About this LexChat collection

Publisher and coverage

LexChat is published by Esheria. Coverage reflects the legislation currently mapped from identified source collections; it may be incomplete, delayed, or later corrected. The official source controls where it differs from this research page.

AI and research method

AI-generated material is explicitly labelled and published only through LexChat's quality controls. It is a research aid, not the source document.

Corrections and reporting

Report a source mismatch, factual issue, personal-data concern, or licensing question to support@esheria.co.ke. Include this page's URL and the supporting official source so the record can be reviewed, corrected, restricted, or withdrawn.

Legal-information disclaimer

LexChat provides legal information and research tools, not legal advice. Verify currency, status, citations, and jurisdiction with authoritative sources and a qualified professional where appropriate.

In accordance with Council Decision 2013/263/EU(1), the Agreement between the European Union and the Russian Federation on drug precursors (‘the Agreement’) was signed on 4 June 2013, subject to its conclusion at a later date.

Publicly available, excluded from search-engine indexing

About this statute

Search within this statute

Provisions of In accordance with Council Decision 2013/263/EU(1), the Agreement between the European Union and the Russian Federation on drug precursors (‘the Agreement’) was signed on 4 June 2013, subject to its conclusion at a later date.

Ask AI about this statute

Sign in to ask AI about this statute